MedTrace Logo

Short Interval Versus Long Interval Repeated Extracorporeal Shockwave Lithotripsy (ESWL) for 8-15 mm Renal Stones.

NCT07421843 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-02-19

No results posted yet for this study

Summary

Extracorporeal shockwave lithotripsy (ESWL) is one way to treat renal stones. In this clinical trial our goal is to evaluate if two ESWL the same week is equal good and safe to two ESWL 3 weeks regarding renal stones 8-15 mm.

Conditions

  • Kidney Stone

Interventions

PROCEDURE

Extracorporeal shockwave lithotripsy (ESWL)

ESWL, two treatments with an interval of two days or three weeks.

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Magnus Wagenius, MD, PhD · University of Lund

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-04
Primary Completion
2026-04-01
Completion
2026-04-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07421843 on ClinicalTrials.gov